# Engineering a Stable Grb2 Monomer: The W60A Mutation Disrupts Dimerization but Preserves Structural Integrity

**Authors:** Jéssica A. Tedesco, Raphael Vinicius R. Dias, Aléxia S. S. Valadares, Rodrigo A. Fernandes, Giovana Casteluci, Larissa S. S. Santos, Ícaro P. Caruso, Rosangela Itri, Fábio C. L. Almeida, Fernando A. de Melo

PMC · DOI: 10.1021/acsomega.5c11284 · ACS Omega · 2026-02-26

## TL;DR

Researchers created a stable monomeric form of the Grb2 protein by mutating a key residue, W60, which helps study its role in cell signaling without dimerization.

## Contribution

The W60A mutation disrupts Grb2 dimerization while preserving its functional domains, offering a new tool for studying its signaling mechanisms.

## Key findings

- The W60A mutation effectively disrupts Grb2 dimerization, resulting in a stable monomeric form.
- The mutation preserves the structural integrity of key interaction sites like SH3 and SH2 domains.
- The monomeric Grb2 mutant provides a platform to study phosphorylation effects in a monomeric context.

## Abstract

The adaptor protein
Grb2 is a critical regulator in signaling
pathways
responsible for cell growth and proliferation, making it a key target
in various carcinomas. Grb2’s function is intricately linked
to its dynamic equilibrium between monomeric and dimeric states. This
equilibrium is tightly regulated by factors such as protein concentration
and post-translational modifications (e.g., Y160/Y207 phosphorylation),
making it a significant challenge to biophysically isolate the monomeric
form to understand its specific contributions to signaling. The dimerization
interface is complex, and while several residues are involved, the
specific role of W60located at the canonical interfacein
stabilizing this oligomeric state has remained unexplored. Here, we
demonstrate that the W60 residue is a critical link for dimerization.
We engineered a point mutation (W60A) and employed a comprehensive
biophysical approach (including SAXS, NMR, and molecular dynamics)
to characterize its structural and dynamic consequences. Our results
are definitive: the W60A mutation successfully disrupts the dimer
interface, yielding a stable, constitutively monomeric protein in
solution, which adopts a more elongated conformation. Crucially, our
structural analyses suggest that this mutation is highly specific
and nonperturbative, disrupting dimerization while preserving the
structural integrity of canonical interaction sites, including the
SH3 domains (for proline-rich motifs) and the primary phosphotyrosine-binding
pocket of the SH2 domain. This Grb2 W60A mutant therefore serves as
a powerful new biophysical tool to uncouple dimerization from function.
It provides an unprecedented platform to investigate complex regulatory
mechanismssuch as the impact of phosphorylation on Grb2in
a purely monomeric context, overcoming a major challenge in dissecting
its complex signaling roles.

## Linked entities

- **Proteins:** GRB2 (growth factor receptor bound protein 2)

## Full-text entities

- **Genes:** GRB2 (growth factor receptor bound protein 2) [NCBI Gene 2885] {aka ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2}
- **Diseases:** carcinomas (MESH:D009369)
- **Mutations:** W60A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12980414/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12980414/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12980414/full.md

---
Source: https://tomesphere.com/paper/PMC12980414